His main research concerns Internal medicine, Heart failure, Intensive care medicine, Cardiology and Kidney disease. Peter A. McCullough has included themes like Diabetes mellitus and Endocrinology in his Internal medicine study. The concepts of his Heart failure study are interwoven with issues in Placebo and Type 2 Diabetes Mellitus.
Peter A. McCullough has researched Intensive care medicine in several fields, including Acute kidney injury, Cardiorenal syndrome, Kidney and Emergency medicine. His Cardiology research includes elements of Cause of death and Diastole. His Kidney disease study combines topics from a wide range of disciplines, such as Dialysis, Blood pressure and Pathology.
His scientific interests lie mostly in Internal medicine, Cardiology, Heart failure, Intensive care medicine and Kidney disease. His study on Renal function, Myocardial infarction and Acute kidney injury is often connected to In patient as part of broader study in Internal medicine. His Cardiology study integrates concerns from other disciplines, such as Stroke and Retrospective cohort study.
Peter A. McCullough studies Heart failure, namely Natriuretic peptide. His Intensive care medicine study combines topics in areas such as Randomized controlled trial, Cardiorenal syndrome, Clinical trial and Disease. His Kidney disease research incorporates themes from Urology, Diabetes mellitus, Anemia, Kidney and Dialysis.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Heart failure, Intensive care medicine and Kidney disease. Peter A. McCullough incorporates Internal medicine and In patient in his studies. Peter A. McCullough studied Cardiology and Stroke that intersect with Mechanical ventilation.
The various areas that Peter A. McCullough examines in his Heart failure study include Diabetes mellitus, Regurgitation, Angiotensin-converting enzyme and Acute kidney injury. He usually deals with Intensive care medicine and limits it to topics linked to Clinical trial and Antithrombotic. His research investigates the link between Kidney disease and topics such as Kidney transplantation that cross with problems in Perioperative.
His primary areas of study are Internal medicine, Intensive care medicine, Heart failure, Kidney disease and Diabetes mellitus. His work on Cardiology expands to the thematically related Internal medicine. His studies deal with areas such as Stroke and Mechanical ventilation as well as Cardiology.
The Intensive care medicine study combines topics in areas such as Dialysis, Randomized controlled trial, Pathophysiology and Clinical trial. His Heart failure research integrates issues from Angiotensin-converting enzyme, Angiotensin receptor, Emergency medicine and Renal function. His work carried out in the field of Kidney disease brings together such families of science as Adverse effect, Disease, Hemodialysis and Urology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
Alan S. Maisel;Padma Krishnaswamy;Richard M. Nowak;James McCord.
The New England Journal of Medicine (2002)
Acute Renal Failure After Coronary Intervention: Incidence, Risk Factors, and Relationship to Mortality
Peter A McCullough;Robert Wolyn;Leslie L Rocher;Robert N Levin.
The American Journal of Medicine (1997)
B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study.
Peter A. McCullough;Richard M. Nowak;James McCord;Judd E. Hollander.
Circulation (2002)
Contrast-Induced Acute Kidney Injury
Peter A. McCullough.
Journal of the American College of Cardiology (2008)
Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes: A Collaborative Meta-analysis of Randomized Trials
Shamir R. Mehta;Christopher P. Cannon;Keith A. A. Fox;Lars Wallentin.
JAMA (2005)
K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease
Andrew S. Levey;Michael V. Rocco;Sharon Anderson;Sharon P. Andreoli.
American Journal of Kidney Diseases (2004)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried;Nicholas Emanuele;Nicholas Emanuele;Jane H. Zhang;Mary Brophy.
The New England Journal of Medicine (2013)
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.
Kianoush B Kashani;Ali Al-Khafaji;Thomas Ardiles;Antonio Artigas.
Critical Care (2013)
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Charles A. Herzog;Charles A. Herzog;Richard W. Asinger;Richard W. Asinger;Alan K. Berger;David M. Charytan.
Kidney International (2011)
Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study
Peter A McCullough;Edward F Philbin;John A Spertus;Scott Kaatz.
Journal of the American College of Cardiology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, San Diego
University of Padua
University of Chicago
The Ohio State University
Thomas Jefferson University
University of California, Los Angeles
Akershus University Hospital
University of California, San Francisco
Stanford University
University of Miami
Stockholm School of Economics
University of Mannheim
Stanford University
University of Alberta
Brigham and Women's Hospital
University of Liverpool
University of Nottingham
Cancer Research UK London Research Institute
Drexel University
Duke University
Ghent University
Northeastern University
University of Adelaide
University of Birmingham
University of Oxford
University of Illinois at Urbana-Champaign